CN102823723B - 一种核苷多肽组合物、其制备方法及用途 - Google Patents
一种核苷多肽组合物、其制备方法及用途 Download PDFInfo
- Publication number
- CN102823723B CN102823723B CN201210306231.6A CN201210306231A CN102823723B CN 102823723 B CN102823723 B CN 102823723B CN 201210306231 A CN201210306231 A CN 201210306231A CN 102823723 B CN102823723 B CN 102823723B
- Authority
- CN
- China
- Prior art keywords
- nucleoside
- polypeptide
- dna
- peptide composition
- enzymolysis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 87
- 239000002777 nucleoside Substances 0.000 title claims abstract description 86
- 150000003833 nucleoside derivatives Chemical class 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229920001184 polypeptide Polymers 0.000 title abstract description 61
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract description 61
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 27
- 102000004190 Enzymes Human genes 0.000 claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 claims abstract description 22
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 230000008569 process Effects 0.000 claims abstract description 4
- 229940088598 enzyme Drugs 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 19
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 16
- 241000965254 Apostichopus japonicus Species 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- 239000000084 colloidal system Substances 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 230000036039 immunity Effects 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 9
- 108091005804 Peptidases Proteins 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 239000002002 slurry Substances 0.000 claims description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 8
- 108010019160 Pancreatin Proteins 0.000 claims description 7
- 229940055695 pancreatin Drugs 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000010792 warming Methods 0.000 claims description 5
- 241000972773 Aulopiformes Species 0.000 claims description 4
- 241001233037 catfish Species 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000019515 salmon Nutrition 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 241001275829 Squaliobarbus Species 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 16
- 102000053602 DNA Human genes 0.000 abstract description 14
- 108020004414 DNA Proteins 0.000 abstract description 14
- 238000010521 absorption reaction Methods 0.000 abstract description 7
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract description 4
- 241000251511 Holothuroidea Species 0.000 abstract description 4
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract description 4
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 abstract description 4
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 abstract description 4
- 238000009826 distribution Methods 0.000 abstract description 3
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 abstract 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 5
- 125000003835 nucleoside group Chemical group 0.000 abstract 3
- 239000005549 deoxyribonucleoside Substances 0.000 abstract 2
- 239000002342 ribonucleoside Substances 0.000 abstract 2
- 108010056119 protease So Proteins 0.000 abstract 1
- -1 absorb Chemical class 0.000 description 44
- 241000699670 Mus sp. Species 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 16
- 230000037396 body weight Effects 0.000 description 16
- 230000009182 swimming Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 102000039446 nucleic acids Human genes 0.000 description 10
- 108020004707 nucleic acids Proteins 0.000 description 10
- 150000007523 nucleic acids Chemical class 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000002773 nucleotide Substances 0.000 description 9
- 125000003729 nucleotide group Chemical group 0.000 description 9
- 238000003304 gavage Methods 0.000 description 8
- 229920002477 rna polymer Polymers 0.000 description 8
- 210000002966 serum Anatomy 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000019688 fish Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 241000251468 Actinopterygii Species 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 4
- 206010018910 Haemolysis Diseases 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229940096919 glycogen Drugs 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000000822 natural killer cell Anatomy 0.000 description 4
- 230000000242 pagocytic effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- 108091028664 Ribonucleotide Proteins 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002336 ribonucleotide Substances 0.000 description 3
- 125000002652 ribonucleotide group Chemical group 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 241000258161 Stichopus Species 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000005314 correlation function Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 238000003801 milling Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000005121 nitriding Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000006200 vaporizer Substances 0.000 description 2
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000258955 Echinodermata Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229930186900 holotoxin Natural products 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | 动物数(只) | 耳肿程度(mg) |
正常对照组 | 10 | 5.00±0.67 |
复合核苷多肽低剂量组 | 10 | 6.65±0.86 |
复合核苷多肽中剂量组 | 10 | 6.78±0.93 |
复合核苷多肽高剂量组 | 10 | 6.87±0.89 |
组别 | 动物数(只) | 小鼠半数溶血值 |
正常对照组 | 10 | 130.1±21.6 |
复合核苷多肽低剂量组 | 10 | 142.1±18.8 |
复合核苷多肽中剂量组 | 10 | 174.8±16.1 |
复合核苷多肽高剂量组 | 10 | 176.0±17.9 |
组别 | 动物数(只) | 吞噬率/% | 吞噬指数 |
正常对照组 | 10 | 20.6±2.6 | 0.33±0.06 |
复合核苷多肽低剂量组 | 10 | 24.8±5.0 | 0.34±0.05 |
复合核苷多肽中剂量组 | 10 | 24.9±3.6 | 0.36±0.07 |
复合核苷多肽高剂量组 | 10 | 29.7±6.1 | 0.43±0.06 |
组别 | 动物数(只) | 小鼠NK细胞活性% |
正常对照组 | 10 | 6.60±1.21 |
复合核苷多肽低剂量组 | 10 | 8.78±1.48 |
复合核苷多肽中剂量组 | 10 | 8.98±1.32 |
复合核苷多肽高剂量组 | 10 | 9.81±1.29 |
组别 | 动物数(只) | 游泳时间/min | P值比较 |
正常对照组 | 10 | 2.60±1.21 | -- |
复合核苷多肽低剂量组 | 10 | 4.18±1.90 | <0.05 |
复合核苷多肽中剂量组 | 10 | 4.78±2.42 | <0.01 |
复合核苷多肽高剂量组 | 10 | 4.81±1.89 | <0.01 |
组别 | 动物数(只) | 血清尿素(mmol/L) | P值比较 |
正常对照组 | 10 | 10.16±1.51 | -- |
复合核苷多肽低剂量组 | 10 | 8.62±1.02 | <0.05 |
复合核苷多肽中剂量组 | 10 | 8.46±1.26 | <0.05 |
复合核苷多肽高剂量组 | 10 | 8.13±1.43 | <0.01 |
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210306231.6A CN102823723B (zh) | 2012-08-27 | 2012-08-27 | 一种核苷多肽组合物、其制备方法及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210306231.6A CN102823723B (zh) | 2012-08-27 | 2012-08-27 | 一种核苷多肽组合物、其制备方法及用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102823723A CN102823723A (zh) | 2012-12-19 |
CN102823723B true CN102823723B (zh) | 2014-02-26 |
Family
ID=47327194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210306231.6A Active CN102823723B (zh) | 2012-08-27 | 2012-08-27 | 一种核苷多肽组合物、其制备方法及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102823723B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103783480B (zh) * | 2014-02-13 | 2017-05-24 | 李洁 | 一种以香菇柄为原料制作天然营养增味剂的工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101143891A (zh) * | 2007-08-24 | 2008-03-19 | 天津天狮生物发展有限公司 | 鱼精多肽中的抗氧化二肽的分离纯化工艺 |
CN101191139A (zh) * | 2007-04-28 | 2008-06-04 | 付学军 | 海参多肽、多糖的综合提取工艺 |
CN101371918A (zh) * | 2007-08-24 | 2009-02-25 | 天津天狮生物发展有限公司 | 鱼精多肽中的抗氧化二肽的新用途 |
CN101514354A (zh) * | 2009-02-25 | 2009-08-26 | 山东大学 | 一种海参多肽及其制备方法与应用 |
-
2012
- 2012-08-27 CN CN201210306231.6A patent/CN102823723B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101191139A (zh) * | 2007-04-28 | 2008-06-04 | 付学军 | 海参多肽、多糖的综合提取工艺 |
CN101143891A (zh) * | 2007-08-24 | 2008-03-19 | 天津天狮生物发展有限公司 | 鱼精多肽中的抗氧化二肽的分离纯化工艺 |
CN101371918A (zh) * | 2007-08-24 | 2009-02-25 | 天津天狮生物发展有限公司 | 鱼精多肽中的抗氧化二肽的新用途 |
CN101514354A (zh) * | 2009-02-25 | 2009-08-26 | 山东大学 | 一种海参多肽及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102823723A (zh) | 2012-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101731665B (zh) | 一种鳄鱼组织的酶解方法及鳄鱼酒的制备方法 | |
CN104664039A (zh) | 一种具有降尿酸活性的秋刀鱼美拉德肽及其制法和应用 | |
CN105132491B (zh) | 一种茯苓多糖的提取方法 | |
CN101979652A (zh) | 一种具有抗氧化活性的四角蛤蜊蛋白多肽及其制备方法和应用 | |
CN105876764A (zh) | 一种发酵菌菇酱的制备技术 | |
CN107772076B (zh) | 一种虫草基饲用免疫增强剂及其制备方法 | |
CN105029429A (zh) | 一种富含γ-氨基丁酸的食品添加剂及其制备方法 | |
CN101401821A (zh) | 蜂花粉肽片及其制备方法 | |
CN104418944A (zh) | 玉米胚芽多种生物活性成分的分离技术 | |
CN106854232B (zh) | 一种骨髓蛋白质的制备方法及其应用 | |
CN104757560A (zh) | 一种谷胱甘肽酵母酶解组合物及其制备方法 | |
CN102823723B (zh) | 一种核苷多肽组合物、其制备方法及用途 | |
CN102077897A (zh) | 一种鱼水解蛋白粉制备方法及其制备的一种鱼水解蛋白粉 | |
CN103409487B (zh) | 一种玉米胚芽活性成分的提取方法 | |
CN101974460A (zh) | 一种海洋来源Bacillus barbaricus SCSIO 02429以及用它制备鱿鱼小肽的方法 | |
AU2009227183A1 (en) | Enteral nutrient | |
CN107674902A (zh) | 一种具有降血糖功能的驼血多肽及其制备方法 | |
Cho et al. | Single-and repeated-dose toxicities of aloe fermentation products in rats | |
On et al. | Amino acids composition of some wild edible mushrooms from southern cross river state, Nigeria | |
CN116478237B (zh) | 一种胰脂肪酶抑制多肽组合及其制备方法、应用 | |
CN108740358A (zh) | 一种饲料添加剂及其制备方法与应用 | |
CN116284220B (zh) | 一种胆固醇酯酶抑制多肽组合及其制备方法、应用 | |
CN101530202A (zh) | 鲟鱼精华口服液及其制备方法 | |
Le et al. | The effect of Zn on the Zn accumulation and biosynthesis of amino acids in mycelia of Cordyceps sinensis | |
CN105105135A (zh) | 一种降脂多肽组合物的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20121219 Assignee: Qingdao great wave hi tech biological Co Ltd Assignor: Chu Dabo Contract record no.: 2014370000125 Denomination of invention: Nucleoside polypeptide composition as well as preparation method thereof and purpose thereof Granted publication date: 20140226 License type: Exclusive License Record date: 20140725 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170914 Address after: 266000, No. 287 Century Avenue, Pingdu Economic Development Zone, Shandong, Qingdao Patentee after: Qingdao great wave hi tech biological Co Ltd Address before: 266000, Pingdu Road, Shandong province brokerage Technology Development Zone No. 287 Patentee before: Chu Dabo |
|
TR01 | Transfer of patent right |